MIST
$5.68
Milestone Pharmaceuticals
$.11
1.97%
MIST
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.49)
Revenue:  $0.00 Mil
Wednesday
Nov 11
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MIST reports earnings?
Beat
Meet
Miss

Where is MIST's stock price going from here?
Up
Flat
Down
Stock chart of MIST
Analysts
Summary of analysts' recommendations for MIST
Score
Grade
Pivots
Resistance
$6.78
$6.41
$6.05

$5.68

Support
$5.32
$4.95
$4.59
Tweet
Growth
Description
Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr?al, Canada.